Abstract
Antacids (Maalox aluminumhydroxide/magnesium hydroxide) can reduce the oral bioavailability of gabapentin by 20 %. To avoid problems, administration of gabapentin and antacids should be separated by at least 2 h [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Busch JA, Radulovic LL, Bockbrader HN, Underwood BA, Sedman AJ, Chang T. Effect of Maalox TC on single-dose pharmacokinetics of gabapentin capsules in healthy subjects. Pharm Res. 1992;9 (Suppl 2):S315.
Sternieri E, Coccio CPR, Pinetti D, Guerzoni S, Ferrari A. Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments. Expert Opin Drug Metab Toxicol. 2006;2:981–1007.
Lal R, Sukbuntherng J, Luo W, Vicente V, Blumenthal R, Ho J, Cundy KC. Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transporter prodrug of gabapentin, with naproxen and cimetidine. Br J Clin Pharmacol. 2010;69:498–507.
Busch JA, Bockbrader HN, Randinitis EJ, Chang T, Welling PG, Reece PA, Underwood B, Sedman AJ, Vollmer KO, Turck D. Lack of clinically significant drug interactions with Neurontin (Gabapentin). In: 20th international epilepsy congress, Oslo, July 1993, Abstract 013958.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Patsalos, P.N. (2013). Gabapentin. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_35
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2434-4_35
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2433-7
Online ISBN: 978-1-4471-2434-4
eBook Packages: MedicineMedicine (R0)